课题基金 / 基金详情

The Roles of the Microbiome and Metabolome in Vascular Aging

The Roles of the Microbiome and Metabolome in Vascular Aging
微生物组和代谢组在血管衰老中的作用
批准号:
9334676
负责人:
Tanika Nicole Kelly
金额:
$26.34万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-11-30

项目摘要

项目成果

Tanika Nicole Kelly的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):拟议研究的总体目标是在Bogalusa心脏研究(BHS)的300名参与者中检查微生物组和代谢组在血管老化中的交叉作用。BHS是由美国国立卫生研究院资助的一项关于整个生命周期内血管健康的纵向研究。目前的随访包括1257名参与者,他们正在接受仔细的血管老化参数评估,包括动脉僵硬、亚临床动脉粥样硬化、中央主动脉血压以及心脏结构和功能的非侵入性测量。利用这些数据,我们将随机选择300名参与者进行微生物组测序和代谢组量化。这一抽样策略将使我们能够有效和有力地检查微生物区系和代谢物对血管老化的多个参数的影响,包括以前从未探索过的关联。我们将使用下一代技术对BHS参与者的粪便样本中的肠道微生物群落进行16S rRNA测序。将利用生物信息学工具将产生的大量原始数据转化为最终产品,其中包括已确定分类群的相对丰度信息,以及微生物区系阿尔法和贝塔多样性的综合指标。在多变量分析中,将测试单个和整体成分指标与血管老化参数的相关性。通过实施最先进的测序方法和复杂的分析技术,我们的研究将是第一批直接探索微生物区系与血管老化关系的研究之一。然后,将使用LC-MS和GC-MS技术相结合的创新方法进行非定向代谢组谱分析。一条自动化管道将被用于将原始代谢组学数据处理成相对代谢物浓度的操作矩阵。先进的多变量方法将被用来测试个体代谢物和整体代谢物与血管老化的相关性。由于我们将使用之前收集的血浆样本和表型数据,建议的分析是非常经济有效的。为了更好地了解将微生物组与表型联系起来的生物途径,我们将测试微生物区系是否影响个体代谢物和代谢组谱。这项分析将是首批全面探索肠道微生物区系与人类血浆代谢物库之间关系的分析之一,除了提供 作为对心血管疾病发生的生物学途径的重要机制洞察,拟议的研究可能有助于根据他们的微生物区系和代谢组学特征及早识别出心血管疾病的高危个体。在这项工作的基础上,可以开发量身定制的策略来改变特定的血管衰老相关微生物区系和代谢物,有可能通过降低心血管疾病的发病率和死亡率来促进健康衰老和长寿。疾病(CVD)进展。
英文摘要
 DESCRIPTION (provided by applicant): The overall objective of the proposed study is to examine the intersecting roles of the microbiome and metabolome in vascular aging among 300 participants of the Bogalusa Heart Study (BHS). The BHS is an NIH-funded longitudinal study of vascular health across the lifespan. The current follow-up includes 1,257 participants who are undergoing careful assessment of vascular aging parameters, including non- invasive measures of arterial stiffness, subclinical atherosclerosis, central aortic blood pressure, and cardiac structure and function. Taking advantage of these data, we will randomly select 300 participants for microbiome sequencing and metabolome quantification. This sampling strategy will allow us to efficiently and powerfully examine the influence of microbiota and metabolites on multiple parameters of vascular aging, including associations which have not been explored previously. We will use next generation technology to conduct 16S rRNA sequencing of gut microbial communities from fecal samples of BHS participants. Bioinformatics tools will be utilized to transform the large amount of generated raw data to an end-product with information on the relative abundance of identified taxa, as well as composite metrics of microbiota alpha and beta diversity. Individual and overall compositional metrics will be tested for association with vascula aging parameters in multivariable analyses. Through the implementation of state-of-the-art sequencing methods and sophisticated analytic techniques, our research will be among the first to directly explore the relation of microbiota with vascular aging. Untargeted metabolomic profiling will then be conducted using innovative methodology that combines LC-MS and GC-MS technologies. An automated pipeline will be used to process raw metabolomics data into an operational matrix of relative metabolite concentrations. Advanced multivariable methods will be used to test associations of individual metabolites and overall metabolomic profile with vascular aging. Since we will use previously collected plasma samples and phenotype data, the proposed analysis is extremely cost-effective. To better understand the biological pathways linking microbiome to phenotype, we will test whether microbiota influence individual metabolites and metabolomic profiles. This analysis will be among the first to comprehensively explore the relation of gut microbiota to the human plasma metabolite repertoire, contributing critical information on the biological pathways influencing cardiovascular In addition to providing important mechanistic insights into the biological pathways underlying CVD development, the proposed research may aid in the early identification of individuals at high risk for CVD based on their microbiota and metabolomic profiles. Based on this work, tailored strategies may be developed to alter specific vascular aging related microbiota and metabolites, with the potential to promote healthy aging and longevity through the reduction of CVD morbidity and mortality. disease (CVD) progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
  • 批准号:
    10620348
  • 项目类别:
  • 资助金额:
    $62.84万
  • 财政年份:
    2022
  • 负责人:
    Tanika Nicole Kelly
  • 依托单位:
Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
  • 批准号:
    10731295
  • 项目类别:
  • 资助金额:
    $72.51万
  • 财政年份:
    2022
  • 负责人:
    Tanika Nicole Kelly
  • 依托单位:
CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CHRONIC KIDNEY DISEASE PATIENTS
  • 批准号:
    10220344
  • 项目类别:
  • 资助金额:
    $71.86万
  • 财政年份:
    2021
  • 负责人:
    Tanika Nicole Kelly
  • 依托单位:
The Roles of the Microbiome and Metabolome in Vascular Aging
  • 批准号:
    9018224
  • 项目类别:
  • 资助金额:
    $16.02万
  • 财政年份:
    2016
  • 负责人:
    Tanika Nicole Kelly
  • 依托单位:
海外基金